Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The pathophysiology of airway dysfunction.

Dennis E Doherty1

  • 1Chandler Medical Center, Division of Pulmonary and Critical Care Medicine, University of Kentucky, Lexington, Kentucky 40536-0284, USA.

The American Journal of Medicine
|February 8, 2005
PubMed
Summary

Asthma and chronic obstructive pulmonary disease (COPD) are distinct inflammatory lung diseases. Understanding their different causes and inflammation patterns is key to choosing the right treatments, with bronchodilators for COPD and anti-inflammatories for asthma.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GOLD in Practice: Chronic Obstructive Pulmonary Disease Treatment and Management in the Primary Care Setting.

International journal of chronic obstructive pulmonary disease·2021
Same author

Correction to: Strategies to Reduce Errors Associated with 2‑Component Vaccines.

Pharmaceutical medicine·2021
Same author

Strategies to Reduce Errors Associated with 2-Component Vaccines.

Pharmaceutical medicine·2020
Same author

Tiotropium Respimat Efficacy and Safety in Asthma: Relationship to Age.

The journal of allergy and clinical immunology. In practice·2020
Same author

The Fibrosis Across Organs Symposium: A Roadmap for Future Research Priorities.

The American journal of the medical sciences·2019
Same author

Office Spirometry in Primary Care for the Diagnosis and Management of COPD: National Lung Health Education Program Update.

Respiratory care·2018

Area of Science:

  • Pulmonary Medicine
  • Immunology
  • Pharmacology

Background:

  • Asthma and COPD are distinct inflammatory airway diseases with different underlying mechanisms.
  • Asthma involves reversible airflow limitation and eosinophilic inflammation, while COPD features progressive, partially reversible airflow limitation with neutrophilic inflammation.

Purpose of the Study:

  • To highlight the critical differences in pathophysiology and inflammatory profiles between asthma and COPD.
  • To emphasize how these distinctions necessitate different therapeutic strategies for optimal patient management.

Main Methods:

  • Comparative analysis of the pathophysiologic mechanisms and cellular inflammatory profiles in asthma versus COPD.
  • Review of current treatment guidelines for both conditions, focusing on first-line and second-line pharmacologic interventions.

Related Experiment Videos

Main Results:

  • Asthma treatment prioritizes anti-inflammatory agents (inhaled corticosteroids, leukotriene-modifiers) due to eosinophilic inflammation and reversible airflow limitation.
  • COPD management emphasizes bronchodilators, particularly anticholinergics, as first-line therapy for cholinergically mediated bronchoconstriction and progressive airflow limitation.

Conclusions:

  • Distinct inflammatory pathways and airflow limitation characteristics in asthma and COPD mandate divergent treatment approaches.
  • Correctly identifying the disease is crucial for implementing appropriate therapeutic strategies, ensuring effective management of each condition.